Stonehage Fleming (UK) Ltd - SYNAGEVA BIOPHARMA CORP ownership

Quarter-by-quarter ownership
Stonehage Fleming (UK) Ltd ownership history of SYNAGEVA BIOPHARMA CORP
ValueSharesWeighting
Q4 2014$19,000
+171.4%
206
+96.2%
0.01%
+200.0%
Q3 2014$7,000
-78.1%
105
-65.6%
0.00%
-76.9%
Q2 2014$32,000
-17.9%
305
-35.8%
0.01%
-18.8%
Q1 2014$39,0004750.02%
Other shareholders
SYNAGEVA BIOPHARMA CORP shareholders Q3 2023
NameSharesValueWeighting ↓
Baker Brothers Advisors 9,223,182$387,189,0007.66%
EMERALD MUTUAL FUND ADVISERS TRUST 78,486$3,295,0000.56%
COLUMBIA WANGER ASSET MANAGEMENT LLC 2,485,288$104,382,0000.46%
HARVEY CAPITAL MANAGEMENT INC 34,800$1,460,0000.45%
EMERALD ADVISERS, LLC 148,232$6,223,0000.38%
DRIEHAUS CAPITAL MANAGEMENT LLC 148,411$6,233,0000.27%
ArrowMark Colorado Holdings LLC 15,500$651,0000.18%
CR Intrinsic Investors, LLC 118,161$4,963,0000.17%
BB BIOTECH AG 53,549$2,248,0000.16%
TURNER INVESTMENTS LLC 209,744$8,806,0000.12%
View complete list of SYNAGEVA BIOPHARMA CORP shareholders